Molecular markers of resistance to amodiaquine plus sulfadoxine–pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger-Reference-Cited by-同舟云学术

Molecular markers of resistance to amodiaquine plus sulfadoxine–pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger

Published:2018-02-27 Issue:1 Volume:17 Page:
ISSN:1475-2875
Container-title:Malaria Journal
language:en
Short-container-title:Malar J

Author:

Grais Rebecca F.^ORCID,Laminou Ibrahim M.,Woi-Messe Lynda,Makarimi Rockyath,Bouriema Seidou H.,Langendorf Celine,Amambua-Ngwa Alfred,D’Alessandro Umberto,Guérin Philippe J.,Fandeur Thierry,Sibley Carol H.

Funder

Médecins Sans Frontières

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Parasitology

Link

http://link.springer.com/content/pdf/10.1186/s12936-018-2242-4.pdf

Reference35 articles.

1. WHO. World malaria report 2016. Geneva: World Health Organization; 2016. http://www.who.int/malaria/publications/world_malaria_report_2016/en/ . Accessed 1 Dec 2017.

2. Ministère de la Santé du Niger/OMS. Bulletins d’information hebdomadaires et données sanitaires. Annuaire des statistiques sanitaires du Niger, année 2012. http://www.snis.cermes.net/donnees.php . Accessed 1 Jan 2017.

3. WorldWide Antimalarial Resistance Network Lumefantrine PK/PD Study Group. Artemether–lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data. BMC Med. 2015;13:227.

4. WHO. Seasonal malaria chemoprevention with sulfadoxine–pyrimethamine plus amodiaquine in children: a field guide. Geneva: World Health Organization; 2013. http://www.who.int/malaria/publications/atoz/9789241504737/en/ . Accessed 1 Jan 2017.

5. Cissé B, Sokhna C, Boulanger D, Milet J, el Bâ H, Richardson K, et al. Seasonal intermittent preventive treatment with artesunate and sulfadoxine–pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet. 2006;367:659–67.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic polymorphism of merozoite surface protein 1 and antifolate-resistant genes in Plasmodium falciparum from Mali and Niger;Parasites, Hosts and Diseases;2023-11-28

2. Polymorphism of Drug Resistance Genes dhfr and dhps in Plasmodium falciparum Isolates among Chinese Migrant Workers Who Returned from Ghana in 2013;Tropical Medicine and Infectious Disease;2023-11-19

3. Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine–pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study;The Lancet Infectious Diseases;2023-03

4. A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria;Malaria Journal;2023-03-01

5. Sanger Sequencing and Deconvolution of Polyclonal Infections: A Quantitative Approach to Monitor Drug-Resistant Plasmodium Falciparum;2023